drugset / Trial / NCT01455012

Effects of Neupro on Cardiovascular Observations in Patients With Restless Legs Syndrome

NCT01455012

Phase 4 Completed 81 enrolled UCB BIOSCIENCES, Inc.
RandomizedParallel-groupDouble-blindTreatment

Summary

Periodic Limb Movements (PLMs) during sleep in patients with Restless Legs Syndrome (RLS) have been shown to be associated with elevations in Blood Pressure (BP). Rotigotine has been shown to effectively reduce the incidence of PLMs in patients with RLS. The current study aims to demonstrate that treatment with Rotigotine could help reduce the number of nocturnal BP elevations associated with PLMs in patients with RLS.

Timeline

Start
2011-09
Primary completion
2012-05
Completion
2012-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Rotigotine Unknown 1 mg
Subject Rotigotine Unknown 2 mg
Subject Rotigotine Unknown 3 mg